Abstract:Skin and soft tissue infections rank among the most frequent infections worldwide. Classic erysipelas is defined as a non-purulent infection by beta-hemolytic streptococci. The typical signs are tender, warm, bright erythema with tongue-like extensions and early systemic symptoms such as fever or at least chills. Erysipelas always and best responds to penicillin. Limited soft tissue infection or limited cellulitis are the terms we have introduced for infections frequently caused by S. aureus and often originating from chronic wounds or acute trauma. Clinically, they are marked by tender, erythematous swelling which, unlike erysipelas, exhibit a darker red hue and is not always accompanied by fever or chills at onset. Severe cellulitis is a purulent, partially necrotic infection extending to the fascia, with general symptoms of infection, requiring surgical management in addition to antibiotics. It often fulfils criteria of so-called complicated soft tissue infections according to the definition of the FDA, due to their frequent association with e.g. severe diabetes mellitus, peripheral arterial occlusive disease or severe immunosuppression. In contrast, the rare necrotizing skin and soft tissue infections represent a distinct entity, characterized by rapid progression to ischemic necroses and shock due to special bacterial toxins. Limited cellulitis should be treated with cephalosporins group 1 or 2, or, when S.aureus is the isolated or highly likely causative agent, isoxazolyl-penicillins (exploiting their minimal selection pressure on other bacteria). For severe cellulitis, initial antibiotic treatment (mostly iv) includes - depending on the location - agents also active against gram-negative and/or anaerobic bacteria. (e.g. clindamycine, aminopeniclilline with inhibitors of betalaktamase, fluochinolons, cephalosporines group 4). For cutaneous abscesses, drainage presents the therapy of choice. Only under certain conditions additional antibiotic therapy is required. Adherence to the diagnostic criteria and to evidence-based or consensus-derived treatment recommendations as presented herein should allow for an antibiotic therapy with a good balance of efficacy, tolerability by patients and low selection pressure for highly resistant bacteria.

Microbiology and management of soft tissue and muscle infections

Microbiology and management of joint and bone infections due to anaerobic bacteria

Skin Infections and Outpatient Burn Management: Bacterial Skin Infections

Skeletal infections: microbial pathogenesis, immunity and clinical management

Hospitalist perspective on the treatment of skin and soft tissue infections

The role of Gram-negative bacteria in skin and soft tissue infections

How to manage skin and soft-tissue infections in the emergency department

Secondary bacterial infections complicating skin lesions

Skin manifestations of Pseudomonas aeruginosa infections

Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment

Cellulitis: current insights into pathophysiology and clinical management

Fournier's gangrene. A clinical review

Diagnosis and Management of Cellulitis and Abscess in the Emergency Department Setting: An Evidence-Based Review

Necrotizing Soft Tissue Infections: A Review

Staphylococcus aureus in Polymicrobial Skinand Soft Tissue Infections: Impact of Inter-Species Interactionsin Disease Outcome

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

Management of human and animal bite wound infection: An overview

Management and prevention of drug resistant infections in burn patients

A contemporaneous narrative review of Fournier's gangrene

Current Concepts in Diagnosis and Management of Hand Infections

Overview of anaerobic infections in children and their treatment